intraarterial
chemotherapy
cancer
metastatic
liver
twentytwo
patients
cancer
metastatic
liver
treated
intraarterial
infusion
cancer
chemotherapeutic
agents
drugs
introduced
directly
hepatic
artery
patients
aorta
level
celiac
axis
patients
significant
differences
results
observed
groups
patients
received
cancer
chemotherapy
via
hepatic
artery
one
remains
alive
mth
treatment
died
immediate
posttreatment
period
survived
mths
treatment
average
survival
mth
patients
treated
intraaortic
administration
cancer
chemotherapy
died
patients
died
immediate
posttreatment
period
survival
time
remaining
averaged
mth
objective
significant
shrinkage
metastases
liver
observed
patients
treated
intrahepatic
artery
route
via
aorta
lasted
mth
subjective
palliation
observed
patients
treated
intrahepatic
artery
route
intraaortic
route
major
complication
noted
leukopenia
a
lesser
degree
hepatic
failure
patients
poor
metabolic
reserve
received
chemotherapy
irradiation
immediate
past
complications
severe
need
critical
screening
proper
selection
patients
candidates
cancer
chemotherapy
discussed
